Cargando…

Gut Microbiota as Biosensors in Patients With Cirrhosis

Detalles Bibliográficos
Autor principal:	Bajaj, Jasmohan S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6664226/ https://www.ncbi.nlm.nih.gov/pubmed/31132339 http://dx.doi.org/10.1016/j.jcmgh.2019.04.016

Ejemplares similares

Whoop there it is: decoding sleep, cirrhosis, and HE
por: Badal, Bryan D., et al.
Publicado: (2023)

Cirrhosis, bile acids and gut microbiota: Unraveling a complex relationship
por: Ridlon, Jason M, et al.
Publicado: (2013)

Transmitting Diet‐Related Microbial Benefit through Fecal Microbiota Transplant in NASH: Can Microbiota Cut Through the Fat?
por: Acharya, Chathur, et al.
Publicado: (2020)

Gut Microbiota Modulation and Fecal Transplantation: An Overview on Innovative Strategies for Hepatic Encephalopathy Treatment
por: Hassouneh, Ramzi, et al.
Publicado: (2021)

Fecal Microbiota Transplant in Cirrhosis Reduces Gut Microbial Antibiotic Resistance Genes: Analysis of Two Trials
por: Bajaj, Jasmohan S., et al.
Publicado: (2020)

Area Deprivation Index and Gut-Brain Axis in Cirrhosis
por: Bajaj, Jasmohan S., et al.
Publicado: (2022)

Impact of Hepatic Encephalopathy in Cirrhosis on Quality-of-Life Issues
por: Montagnese, Sara, et al.
Publicado: (2019)

Gut Microbiota Alterations can predict Hospitalizations in Cirrhosis Independent of Diabetes Mellitus
por: Bajaj, Jasmohan S., et al.
Publicado: (2015)

Erratum: Gut Microbiota Alterations can predict Hospitalizations in Cirrhosis Independent of Diabetes Mellitus
por: Bajaj, Jasmohan S., et al.
Publicado: (2016)

Impaired Gut-Liver-Brain Axis in Patients with Cirrhosis
por: Ahluwalia, Vishwadeep, et al.
Publicado: (2016)

Distinct gut microbial compositional and functional changes associated with impaired inhibitory control in patients with cirrhosis
por: Bajaj, Jasmohan S, et al.
Publicado: (2021)

Deprescribing medications that may increase the risk of hepatic encephalopathy: A qualitative study of patients with cirrhosis and their doctors
por: Williams, Sydni, et al.
Publicado: (2021)

The human gut sterolbiome: bile acid-microbiome endocrine aspects and therapeutics
por: Ridlon, Jason M., et al.
Publicado: (2015)

Hepatic Branch Vagotomy Modulates the Gut-Liver-Brain Axis in Murine Cirrhosis
por: Zhang, Yuan, et al.
Publicado: (2021)

The Toll of Hyperammonemia on the Brain
por: Saunders, Justin M., et al.
Publicado: (2019)

Tu1264: PATIENTS WITH CIRRHOSIS EXPERIENCE HIGHER ICU MORTALITY COMPARED TO NON-CIRRHOTIC PATIENTS WHICH CONTINUED WITH OR WITHOUT COVID-19 DESPITE CONTROLLING FOR ORGAN FAILURE SEVERITY
por: Park, Dan, et al.
Publicado: (2022)

Characterizing patient-reported outcomes in veterans with cirrhosis
por: Rogal, Shari S., et al.
Publicado: (2020)

Targeting Gut Microbiome Interactions in Service-Related Gastrointestinal and Liver Diseases of Veterans
por: Bajaj, Jasmohan S., et al.
Publicado: (2019)

A specialized HE testing clinic improves rational decision-making for therapy in cirrhosis
por: Nadeem, Mahum, et al.
Publicado: (2023)

The Use of Rifaximin in Patients With Cirrhosis
por: Caraceni, Paolo, et al.
Publicado: (2021)

Advances in Gut Microbiota of Viral Hepatitis Cirrhosis
por: Wang, Yixuan, et al.
Publicado: (2019)

Serum and urinary metabolomics and outcomes in cirrhosis
por: Bajaj, Jasmohan S., et al.
Publicado: (2019)

Elderly patients have an altered gut-brain axis regardless of the presence of cirrhosis
por: Bajaj, Jasmohan S., et al.
Publicado: (2016)

Sa1372: TRACKING CIRRHOSIS CARE DURING COVID-19 PANDEMIC
por: Adejumo, Adeyinka C., et al.
Publicado: (2022)

Abnormal Gut Microbiota Metabolism Specific for Liver Cirrhosis
por: Wei, Xiao, et al.
Publicado: (2018)

Sarcopenia in cirrhosis: Prospects for therapy targeted to gut microbiota
por: Maslennikov, Roman, et al.
Publicado: (2023)

Substance‐use simulation impairs driving capability in patients with cirrhosis regardless of hepatic encephalopathy
por: Acharya, Chathur, et al.
Publicado: (2022)

Outlook on the gut microbiota
por: Schroeder, Bjoern O
Publicado: (2022)

Small Bowel Transit and Altered Gut Microbiota in Patients With Liver Cirrhosis
por: Liu, Yang, et al.
Publicado: (2018)

Liver cirrhosis contributes to the disorder of gut microbiota in patients with hepatocellular carcinoma
por: Zheng, Ruipeng, et al.
Publicado: (2020)

Mindfulness-Based Stress Reduction Therapy Improves Patient and Caregiver-Reported Outcomes in Cirrhosis
por: Bajaj, Jasmohan S, et al.
Publicado: (2017)

Gut Microbiota for Health: How Can Diet Maintain A Healthy Gut Microbiota?
por: Ferraris, Cinzia, et al.
Publicado: (2020)

Not so Splendid for the Gut Microbiota
por: Chassaing, Benoit, et al.
Publicado: (2018)

Gut microbiota’s impact on obesity
por: Jeong, Sujin
Publicado: (2023)

Gut Microbiota According to the Metabolome
por: Scarpellini, Emidio, et al.
Publicado: (2023)

Adventures in Developing an App for Covert Hepatic Encephalopathy
por: Bajaj, Jasmohan S
Publicado: (2017)

Leaky gut-derived tumor necrosis factor-α causes sarcopenia in patients with liver cirrhosis
por: Kawaguchi, Takumi, et al.
Publicado: (2022)

Splenectomy Leads to Amelioration of Altered Gut Microbiota and Metabolome in Liver Cirrhosis Patients
por: Liu, Yang, et al.
Publicado: (2018)

Gut Microbiota Dynamics and Uremic Toxins
por: Mishima, Eikan, et al.
Publicado: (2022)

New Perspectives in Health: Gut Microbiota
por: Cardona, Diana, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_pkvuh5u53704rifn97e1n7bf9t